Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC).

被引：0

作者：

Ikeda, Masafumi

Aramaki, Takeshi

Inaba, Yoshitaka

Nakai, Kenya

Doi, Toshihiko

Okusaka, Takuji

机构：

[1] Natl Canc Ctr Hosp East, Chiba, Japan

[2] Shizuoka Canc Ctr, Shizuoka, Japan

[3] Aichi Canc Ctr Hosp, Dept Intervent & Diagnost Radiol, Nagoya, Aichi 464, Japan

[4] Eisai & Co Ltd, Tokyo, Japan

[5] Natl Canc Ctr, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.2521

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2521

引用

页数：1

共 50 条

[21] Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study [J].

Pishvaian, M. J. ;

Weiss, G. J. ;

Falchook, G. S. ;

Yee, N. ;

Gil-Martin, M. ;

Shahda, S. ;

Moreno, V. ;

Brana, I. ;

Crittenden, M. ;

Formenti, S. ;

Al-Rajabi, R. ;

Papadopoulos, K. P. ;

Stankevich, E. ;

Feng, M. ;

Li, J. ;

Mathias, M. ;

Kroog, G. ;

Lowy, I. ;

Fury, M. G. .

ANNALS OF ONCOLOGY, 2018, 29

[22] A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma [J].

Sakamoto, Junichi ;

Oriuchi, Noboru ;

Mochiki, Erito ;

Asao, Takayuki ;

Scott, Andrew M. ;

Hoffman, Eric W. ;

Jungbluth, Achim A. ;

Matsui, Takanori ;

Lee, F. T. ;

Papenfuss, Anthony ;

Kuwano, Hiroyuki ;

Takahashi, Toshitada ;

Endo, Keigo ;

Old, Lloyd J. .

CANCER SCIENCE, 2006, 97 (11) :1248-1254

[23] A phase I study of ganetespib in advanced hepatocellular carcinoma (HCC) [J].

Goyal, Lipika ;

Wadlow, Raymond Couric ;

Blaszkowsky, Lawrence Scott ;

Wolpin, Brian M. ;

Vasudev, Eamala ;

Sheehan, Susan ;

Knowles, Michelle ;

Zhu, Andrew X. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)

[24] Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) [J].

Chen, L. ;

Shiah, H. S. ;

Chen, C. Y. ;

Lin, Y. J. ;

Lin, P. W. ;

Su, W. C. ;

Chang, J. Y. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[25] Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study [J].

He, A. R. ;

Weiss, G. J. ;

Falchook, G. ;

Yee, N. S. ;

Gil-Martin, M. ;

Shahda, S. ;

Moreno, V. ;

Brana, I. ;

Crittenden, M. ;

Formenti, S. ;

Al-Rajabi, R. ;

Papadopoulos, K. P. ;

Pishvaian, M. J. ;

Stankevich, E. ;

Feng, M. ;

Li, J. ;

Mathias, M. ;

Kroog, G. ;

Lowy, I. ;

Fury, M. G. .

ANNALS OF ONCOLOGY, 2018, 29

[26] Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC). [J].

Finn, R. S. ;

Poon, R. T. P. ;

Yau, T. ;

Klumpen, H. ;

Chen, L. ;

Kang, Y. ;

Kim, T. ;

Gomez-Martin, C. ;

Rodriguez-Lope, C. ;

Kunz, T. ;

Paquet, T. ;

Asubonteng, K. ;

Winkler, R. E. ;

Anak, O. ;

Sellami, D. B. ;

Bruix, J. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[27] Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC) [J].

Yen Chia-Jui ;

Benjamin, Markman ;

Chao Yee ;

Andrew, Hill ;

Kang Jinyu ;

Wang Lai ;

Li Kang ;

Qi Qinzhou ;

Wu Zhong ;

Gan Hui .

ANNALS OF ONCOLOGY, 2017, 28

[28] Phase I/II study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results [J].

Mitsunaga, Shuichi ;

Ikeda, Masafumi ;

Ueno, Hideki ;

Nakachi, Kohei ;

Morizane, Chigusa ;

Kondo, Shunsuke ;

Shimizu, Satoshi ;

Kojima, Yasushi ;

Suzuki, Takuya ;

Tamai, Toshiyuki ;

O'Brien, James P. ;

Okusaka, Takuji .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)

[29] Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC) [J].

Iyer, Renuka ;

Sonti, Sahithi ;

Mahalingam, Devalingam ;

Mukherjee, Sarbajit ;

Chakraborty, Sayan ;

Attwood, Kristopher ;

George, Anthony ;

Maguire, Orla ;

Minderman, Hans ;

Fountzilas, Christos .

CANCER RESEARCH, 2024, 84 (07)

[30] A phase II study of ramucirumab as first-line monotherapy in patients (pts) with advanced hepatocellular carcinoma (HCC) [J].

Zhu, A. X. ;

Finn, R. S. ;

Mulcahy, M. F. ;

Gurtler, J. S. ;

Sun, W. ;

Schwartz, J. D. ;

Rojas, P. ;

Dontabhaktuni, A. ;

Youssoufian, H. ;

Stuart, K. E. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

← 1 2 3 4 5 →